Literature DB >> 3778047

Risk factors for acquiring pneumococcal infections.

B A Lipsky, E J Boyko, T S Inui, T D Koepsell.   

Abstract

To identify risk factors for developing pneumococcal infections, we carried out a case-controlled study on a retrospectively constituted cohort of 3074 clinic patients in a presumed high-risk population. Culture-proved pneumococcal infections were identified in 63 men over a period of 5.5 years, yielding an estimated incidence of 6.3 cases per 1000 person-years. By comparing these patients with 130 uninfected control patients, the relative risk of pneumococcal infections related to various exposures was calculated by logistic regression analysis. Statistically significant independent risk factors (and their relative risks) were as follows: dementia (5.82), seizure disorders (4.38), current cigarette smoking (4.00), congestive heart failure (3.83), cerebrovascular disease (3.82), institutionalization (3.13), and chronic obstructive pulmonary disease (2.38). Risk was increased with age and previous hospitalizations, and, to a nonsignificant degree, by hotel residence (3.93), lung cancer (2.24), previous smoking (2.14), corticosteroid use (1.81), and alcoholism (1.35); but not by diabetes mellitus (0.99), nonlung malignancies (0.93), nonwhite race (0.89), or ischemic heart disease (0.58).

Entities:  

Mesh:

Year:  1986        PMID: 3778047

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  33 in total

1.  Gram-Positive Pneumonia.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

2.  An exploratory spatial analysis of pneumonia and influenza hospitalizations in Ontario by age and gender.

Authors:  E J Crighton; S J Elliott; R Moineddin; P Kanaroglou; R E G Upshur
Journal:  Epidemiol Infect       Date:  2006-07-07       Impact factor: 2.451

3.  Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society.

Authors:  L A Mandell; T J Marrie; R F Grossman; A W Chow; R H Hyland
Journal:  Can J Infect Dis       Date:  2000-09

4.  Identification of new risk factors for pneumonia: population-based case-control study.

Authors:  Yana Vinogradova; Julia Hippisley-Cox; Carol Coupland
Journal:  Br J Gen Pract       Date:  2009-10       Impact factor: 5.386

Review 5.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

Review 6.  Immunosenescence revisited. Does it have any clinical significance?

Authors:  A J Voets; L R Tulner; G J Ligthart
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

Review 7.  Pneumococcal vaccine.

Authors:  R T White
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

8.  Disability and cognitive impairment are risk factors for pneumonia-related mortality in older adults.

Authors:  M E Salive; S Satterfield; A M Ostfeld; R B Wallace; R J Havlik
Journal:  Public Health Rep       Date:  1993 May-Jun       Impact factor: 2.792

9.  PCR Detection of Respiratory Pathogens in Asymptomatic and Symptomatic Adults.

Authors:  Nicklas Sundell; Lars-Magnus Andersson; Robin Brittain-Long; Pär-Daniel Sundvall; Åsa Alsiö; Magnus Lindh; Lars Gustavsson; Johan Westin
Journal:  J Clin Microbiol       Date:  2019-01-02       Impact factor: 5.948

10.  Pneumococcal bacteremia presenting as acute parotitis and sepsis.

Authors:  Ashish Kataria; Alan S Multz
Journal:  Case Rep Med       Date:  2009-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.